The speaker is Louise Baskin, MS, senior product manager, GE Healthcare. Louise, who joined Dharmacon RNA Technologies in 2005, has led the development and commercial launch of multiple genome-wide siRNA and microRNA product lines. She is also responsible for developing and expanding the Dharmacon Edit-R Genome Engineering portfolio, which includes synthetic crRNA and lentiviral sgRNA, in addition to Cas9 nucleases in inducible or constitutive lentiviral vectors, DNA plasmid, mRNA, or protein formats. She works closely with a respected team of R&D scientists on innovative CRISPR-Cas9 tools and services. Louise earned a master's degree in molecular biology and genetics at Northwestern University.

Dr. Belcher is the Functional Leader, Biacore at GE Healthcare. He received his Ph.D. in organic chemistry from the University of Newcastle upon Tyne in the United Kingdom in 2003. During his postdoctoral training, he worked under George Pettit at Arizona State University working on the first total synthesis of the natural product dolastatin 16, a potential cancer therapeutic. While at Arizona State, Paul established a label-free screening program for screening/characterization of large libraries of compounds to enable the development of synthetic probes to challenging targets. At GE his focus has been on the value of drug-target binding kinetics for investigating structure-activity relationships and drug efficacy. He also works on fragment-based lead discovery, interacting predominately with small molecule screening groups within academia and industry to implement and optimize label-free methods for drug discovery. He is a frequent speaker and has given over 500 lectures at conferences and pharma/biotech industry sites and Universities globally.

Marianne has three decades of protein purification experience at GE. She graduated from Umeå University in 1985 with a BSc in Biochemistry then pursued graduate studies. In 1986 Marianne joined Uppsala's Pharmacia LKB Biotechnology, which later became GE. After starting in quality control, Marianne worked for ten years as an R&D method and application specialist, developing chromatography media for both research and BioProcess customers. Marianne held different roles within the Nordic sales organization before joining the product marketing organization, where she has been for the last 15 years. In her current role as a product specialist she has developed and delivered technical protein purification presentations for customers. Marianne has also been involved in creating numerous support materials such as selection guides, apps, and other tools to help guide customers in their protein purification work.

Åke was born in 1953 in Stockholm, Sweden. He graduated from Uppsala University with a M.Sc. in Chemistry / Biology in 1978. He obtained his Ph.D. in veterinary medical chemistry at the Swedish University of Agricultural Sciences, in Uppsala, in 1982. He held a position as Research Associate at the Swedish University of Agricultural Sciences between 1982 and 1986, studying the molecular mechanisms of blood coagulation. He has published several papers on the interaction of the plasma protein inhibitor, antithrombin with heparin and coagulation enzymes. In 1987, Åke joined Pharmacia LKB Biotechnology, which later became GE, in Uppsala. Åke has held a number of different R&D positions in GE Healthcare Life Sciences, most recently as a Staff Scientist and now as Research Director. He has been involved in the development of a number of chromatography resins for protein separations and of the ÄKTATM chromatography systems product line.

James Goldmeyer, PhD, Product Manager at Dharmacon, part of GE Healthcare. James joined Dharmacon in 2009 and has lead the development and commercial launch of numerous genome-wide shRNA and gene-overexpression product lines. He also shares responsibility for, and is heavily involved in the development, of the Dharmacon Edit-R Dharmacon Gene Engineering portfolio; with emphasis on the vector-based products for lentiviral sgRNA and Cas9 nuclease expression. James works closely with an expert group of R&D scientists on innovative tools and services for gene modulation and engineering. James earned a doctorate degree in physiology and neurobiology at the University of Connecticut.

Peter Hagwall has a scientific background in process analytical technologies and surface chemistry. For the last 5 years, Peter has been active as product manager for chromatography resins and focus on tools and methodologies for process development and characterization

Pia has a master degree as Civil Engineer in Molecular Biotechnology from Uppsala University, Sweden. She has been employed at GE Healthcare, Life Sciences for 16 years. The last nine years she has been the global product manager for GE's size exclusion chromatography (SEC) columns, responsible for the introduction of the new generation of
agarose based SEC columns called "Increase".

QuangVu graduated from the University of Washington with a Chemistry degree and an MBA from the University of Maryland. Having over 10+ years in the biotech industry, he is responsible for HyClone's products in research.

Lena brings her background in both analytical chemistry and biochemistry to GE Healthcare where she has been employed for 16 years. For the last 5 years, Lena has been the product owner for UNICORN control software in the R&D department.

Dr. Papalia (Joe) received his undergraduate degree in Biology from the University of Ottawa, Canada. He pursued biophysical studies for both his Masters and Ph.D. degrees at the University of Toronto. Both theses included work using various biophysical techniques including NMR and CD spectroscopy as well as well as X-ray crystallography. For his Post-Doctoral work, Joe moved to Salt Lake City, Utah to study with Dr. David Myszka, a pioneer in biosensor studies to follow-up on his main interest, the thermodynamics and kinetics of molecular interactions. During his time with Dr. Myszka, Joe worked on various projects including GPCRs as well as helping to coordinate several benchmark studies with participants from around the world. These studies helped establish various standards in the biosensor field. In time he was promoted to Staff Scientist at the University of Utah. Joe was subsequently recruited to the Bay Area by Dr. Scott Klakamp to work at Takeda San Francisco where he added to existing biosensors capabilities at Takeda and additionally, complemented his strength in biosensors with studies using KinExA technology. He was subsequently recruited by Gilead Sciences as a Senior Scientist to fulfil various roles including leading biosensor work in the Department of Biochemistry and serving on various core teams where he provides both biophysical insight and guidance.

Markus studied biology at the RWTH Aachen university and joined the group of Rainer Fischer in 1996, then at the department of botany headed by Prof. Kreuzaler where I earned my diploma in biology in 1998 and continued to work at the newly formed department of molecular biology headed by Prof. Fischer. The majority of assays developed were not kinetic assays, but rather the quantification and characterization of various quality attributes of recombinant produced proteins. For almost 20 years, Markus has been in charge of the SPR unit at the Institute for Molecular Biotechnology at the RWTH University and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen. Within this environment SPR is being applied everyday in basic and applied research, from small molecules to antibodies and viruses.

John Schiel is a research scientist at Dharmacon, part of GE Healthcare. He joined the R&D team at Dharmacon in 2014 and is actively involved in developing research tools within the gene modulation and genome editing fields of research which include RNA interference (http://dharmacon.gelifesciences.com/rnai-and-custom-rna-synthesis/) and CRISPR-Cas9 genome engineering (http://dharmacon.gelifesciences.com/gene-editing/crispr-cas9/) He received his Bachelor of Science degree in Biochemistry at Colorado State University and his Ph.D. degree in Cell Biology at the University of Colorado Denver - Anschutz Medical Campus. John completed a postdoctoral fellowship at University of Massachusetts Medical School where he studied asymmetric cell division and centrosome maturation.

Karin did her thesis at the Department of Medical Biochemistry, at Karolinska Institutet, studying the effects of antioxidant proteins in cancer cell signaling. As one of the authors of "Western blotting - Principles and Methods" she is well familiar with the challenges of Western blotting.

Robyn joined Bio-Techne in 2011. She has been a Biosensor Specialist since 2015, performing assays to support existing products and driving new areas of research forward with a blend of biophysical approaches.

Shashank is a Research associate in the Analytical Development department in Momenta Pharmaceuticals. He completed his Bachelors in Engineering from Bangalore, India in C.M.R.I.T. and earned his Master's in Biotechnology from Northeastern University, Boston, MA, USA. He has have worked on Surface Plasmon Resonance (SPR) methods to analyze binding affinity of various molecules in the development pipeline in Momenta pharmaceuticals. His work focuses on developing, optimizing and qualifying SPR methods to obtain highly reproducible, high through-put and robust methods in support of functional characterization of these molecules.

Protein Research Live

Prepare. Purify. Analyze.

What is Protein Research Live?

Protein Research Live is an interactive, educational virtual event showcasing techniques that impact and drive genome and protein research

This virtual event will allow you to explore a range of exciting Life Science research techniques and interact with a panel of experts, without the time and expense of traveling to a conference.

Join us live to learn more, featured techniques include:

Genome research (including RNAi and CRISPR-Cas9)

Recombinant protein production

Protein purification

Protein detection, validation and quantitation

Label-free interaction analysis (SPR)

Why should you attend Protein Research Live?

Protein Research Live is packed with educational and technical resources along with troubleshooting support to assist you with the everyday aspects of your preparation, purification and analysis. This is an exciting new format from GE Life Sciences that allows you to explore the many current techniques being used in genome and protein research.

Take a seat in the auditorium for plenary and keynote presentations

Visit our range of booths in the exhibition hall

Walk the scientific poster session

Raise your questions in our live web chats

Check out this video of our Scientific Chair, Paul Belcher, outlining his highlights in this, the inaugural Protein Research Live!

7:15-8:00am PT, 10:15-11:00am ET

Biacore Booth with experts; Anja Drescher, Paul Belcher, Michael B. Murphy, and Teresa Ferragamo
The Biacore applications team will be available throughout Protein Research Live and the dedicated webchat to discuss the world of label free interaction analysis.

8:15-9:00am PT, 11:15-12:00pm ET

Dharmacon Booth with experts; Crissy Paulson and Coby Cressall
Join the Dharmacon technical team to discuss key genomic technologies such as CRISPR and RNAi